Scottsdale, Arizona
Phase 1 colorectal cancer trials in Scottsdale, AZ
13 Phase 1 colorectal cancer studies are recruiting participants at sites in Scottsdale as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Scottsdale at a glance
- 13 studies are recruiting at a site in Scottsdale.
- By phase: Phase 1 (6), Phase 1/2 (7).
- By sponsor: industry (12), university, hospital or other (1).
- Most recent update to one of these records: November 4, 2026.
Studies recruiting in Scottsdale
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- HonorHealth
- Registry record
- NCT06400472 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Honor Health Research Institute
- Registry record
- NCT07397338 · updated
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- VM Discovery, Inc.
- Study site
- HonorHealth Research Institute (#600)
- Registry record
- NCT07636785 · updated
This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- LTZ Therapeutics, Inc.
- Study site
- HonorHealth Research Institute
- Registry record
- NCT07878988 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Mayo Clinic (Arizona)
- Registry record
- NCT04657068 · updated
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SHY Therapeutics
- Study site
- HonorHealth Research Institute
- Registry record
- NCT07705334 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- Honor Health
- Registry record
- NCT05919264 · updated
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Avacta Life Sciences Ltd
- Study site
- Honor Health Research Institute
- Registry record
- NCT07454642 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- HonorHealth Research Institute
- Registry record
- NCT06445062 · updated
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study site
- Mayo Clinic
- Registry record
- NCT06131840 · updated
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- HonorHealth Research Institute
- Study site
- Clinical Trials Nurse Navigator
- Registry record
- NCT07463599 · updated
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Clasp Therapeutics, Inc.
- Study site
- HonorHealth Research Institute
- Registry record
- NCT06778863 · updated
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- GI Innovation, Inc.
- Study site
- Mayo Clinic in Arizona
- Registry record
- NCT05824975 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Scottsdale, AZ on ClinicalTrials.gov.
Ask about studies near Scottsdale
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections